Intensive voice treatment in Parkinson’s disease: Lee Silverman Voice Treatment

References

• Fisher BE, Wu AD, Salem GJ et al. The effect of exercise training in improving motor performance and corticomotor excitability in people with early Parkinson’s disease. Arch. Phys. Med. Rehabil.89(7), 1221–1229 (2008).
   PubMed Web of Science ®Google Scholar
• Hirsch MA, Farley BG. Exercise and neuroplasticity in persons living with Parkinson’s disease. Eur. J. Phys. Rehabil. Med.45, 215–229 (2009).
   PubMed Web of Science ®Google Scholar
• Petzinger G, Fisher B, Van Leeuwen J-E et al. Enhancing neuroplasticity in the basal ganglia: the role of exercise in Parkinson’s disease. Mov. Disord.25, S141–S145 (2010).
   PubMed Web of Science ®Google Scholar
• Kleim JA, Jones TA. Principles of experience-dependent neural plasticity: implications for rehabilitation after brain damage. J. Speech Lang. Hear. Res.51, S225–S239 (2008).
   PubMed Web of Science ®Google Scholar
• Kleim J, Jones T, Schallert T. Motor enrichment and the induction of plasticity before or after brain injury. Neurochem. Res.11, 1757–1769 (2003).
   Google Scholar
• Zigmond MJ, Cameron JL, Leak RK et al. Triggering endogenous neuroprotective processes through exercise in models of dopamine deficiency. Parkinsonism Relat. Disord.1553, 542–545 (2009).
   Google Scholar
• Keus S, Munneke M, Nijkrake M, Kwakkel G, Bloem B. Physical therapy in Parkinson’s disease: evolution and future challenges. Mov. Disord.24, 1–14 (2009).
   PubMed Web of Science ®Google Scholar
• de Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol.5(6), 525–535 (2006).
   PubMed Web of Science ®Google Scholar
• Ho A, Iansek R, Marigliani C, Bradshaw JL, Gates S. Speech impairment in a large sample of people with Parkinson’s disease. Behav. Neurol.11, 131–137 (1998).
   PubMed Web of Science ®Google Scholar
• Darley F, Aronson A, Brown J. Hypokinetic Dysarthria. In: Motor Speech Disorders. Saunders, PA, USA (1975).
   Google Scholar
• Ho A, Iansek R, Bradshaw JL. Motor instability in Parkinsonian speech intensity. Neuropsychiatry Neuropsychol. Behav. Neurol.14, 109–116 (2001).
   PubMedGoogle Scholar
• Baumgartner C, Sapir S, Ramig LO. Voice quality changes following phonatory-respiratory effort treatment (LSVT®) versus respiratory effort treatment for people with Parkinson disease. J. Voice14, 105–114 (2001).
   Google Scholar
• Adams S. Hypokinetic dysarthria in Parkinson’s disease. In: Clinical Management of Sensorimotor Speech Disorders. McNeil MR (Ed.). Thieme, NY, USA (1997).
   Google Scholar
• Forrest K, Weismer G, Turner G. Kinematic, acoustic and perceptual analysis of connected speech produced by Parkinsonian and normal geriatric adults. J. Acoust. Soc. Am.85, 2608–2622 (1989).
   PubMed Web of Science ®Google Scholar
• Sapir S, Spielman, J, Ramig LO, Story BS, Fox C. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings. J. Speech Lang. Hear. Res.50, 899–912 (2007).
   PubMed Web of Science ®Google Scholar
• Sapir S, Pawlas AA, Ramig LO et al. Voice and speech abnormalities in Parkinson disease: relation to severity of motor impairment, duration of disease, medication, depression, gender, and age. J. Med. Speech Lang. Pathol.9, 213–226 (2001).
   Google Scholar
• Benke T, Hohenstein C, Poewe W, Butterworth B. Repetitive speech phenomena in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry.69, 319–324 (2000).
   PubMed Web of Science ®Google Scholar
• McClean M. Neuromotor aspects of speech production and dysarthria. In: Clinical Management of Dysarthric Speakers. Yorkston KM, Beukelman DR, Bell KR (Eds.). A College-Hill Publication, Little, Brown and Co., CA, USA, 19–58 (1988).
   Google Scholar
• Perez K, Ramig LO, Smith M, Dromey C. The Parkinson larynx: tremor and videostroboscopic findings. J. Voice10, 354–361 (1996).
   PubMed Web of Science ®Google Scholar
• Smith M, Ramig LO, Dromey C, Perez K, Samandari R. Intensive voice treatment in Parkinson’s disease: laryngostroboscopic findings. J. Voice9, 453–459 (1995).
   PubMed Web of Science ®Google Scholar
• Solomon N, Hixon TJ. Speech breathing in Parkinson’s disease. J. Speech Hear. Res.36, 294–310 (1993).
   PubMedGoogle Scholar
• Baker K, Ramig LO, Luschei E, Smith M. Thyroarytenoid muscle activity associated with hypophonia in Parkinson disease and aging. Neurology51, 1592–1598 (1998).
   PubMed Web of Science ®Google Scholar
• Gallena S, Smith PJ, Zeffiro T, Ludlow CL. Effects of levodopa on laryngeal muscle activity for voice onset and offset in Parkinson disease. J. Speech Hear. Res.44, 1284–1299 (2001).
   Google Scholar
• Vincken W, Gauthier SG, Dollfuss RE, Hanson RE, Parauay CM, Cosio MG. Involvement of upper-airway muscles in extrapyramidal disorders, a cause of airflow limitation. N. Engl. J. Med.7, 438–442 (1984).
   Google Scholar
• Ackermann H, Ziegler W. Articulatory deficits in parkinsonian dysarthria. J. Neurol. Neurosurg. Psychiatry.54, 1093–1098 (1991).
   PubMed Web of Science ®Google Scholar
• Ackermann H, Konczak J, Hertrich I. The temporal control of repetitive articulatory movements in Parkinson’s disease. Brain Lang.56, 312–319 (1997).
   PubMed Web of Science ®Google Scholar
• Caligiuri M, Abbs JH. Response properties of the perioral reflex in Parkinson’s disease. Exp. Neurol.98, 563–572 (1987).
   PubMed Web of Science ®Google Scholar
• Hirose H. Pathophysiology of motor speech disorders (dysarthria). Folia Phoniat. Basel38, 61–88 (1986).
   PubMed Web of Science ®Google Scholar
• Leanderson R, Persson A, Ohman S. Electromyographic studies of the function of the facial muscles in dysarthria. Acta Otolaryngol.263, 89–94 (1970).
   Google Scholar
• Leanderson R, Meyerson B, Persson A. Lip muscle function in Parkinsonian dysarthria. Acta Otolaryngol.74, 350–357 (1972).
   PubMed Web of Science ®Google Scholar
• Radad K, Gille G, Rausch W. Short review on dopamine agonists: insight into clinical and research studies relevant to Parkinson’s disease. Pharmacologic Rep.57, 701–712 (2005).
   PubMed Web of Science ®Google Scholar
• Goberman A. Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson disease. Med. Sci. Monit.11, CR109–CR116 (2005).
   PubMed Web of Science ®Google Scholar
• Trail M, Fox C, Ramig LO, Sapir S, Howard J, Lai EC. Speech treatment for Parkinson’s disease. NeuroRehabilitation20, 205–221 (2005).
   PubMed Web of Science ®Google Scholar
• De Letter M, Santens P, Van Borsel J. The effects of levodopa on word intelligibility in Parkinson’s disease. J. Commun. Disord.38, 187–196 (2005).
   PubMed Web of Science ®Google Scholar
• Goberman A, Coelho C, Robb M. Phonatory characteristics of Parkinsonian speech before and after morning medication: the ON and OFF states. J. Commun. Disord.35, 217–239 (2002).
   PubMed Web of Science ®Google Scholar
• Jiang J, Lin E, Wang J, Hanson DG. Glottographic measures before and after levodopa treatment in Parkinson’s disease. Laryngoscope109, 1287–1294 (1999).
   PubMed Web of Science ®Google Scholar
• Sanabria J, Ruiz PG, Gutierrez R et al. The effect of levodopa on vocal function in Parkinson’s disease. Clin. Neuropharmacol.24, 99–102 (2001).
   PubMed Web of Science ®Google Scholar
• Cahill L, Murdoch BE, Theodoros DG, Triggs EJ, Charles BG, Yao AA. Effect of oral levodopa treatment on articulatory function in Parkinson’s disease: preliminary results. Motor Control2, 161–172 (1998).
   PubMedGoogle Scholar
• Kompoliti K, Wang QE, Goetz CG, Leurgans S, Raman R. Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson’s disease. Neurology54, 458–462 (2000).
   PubMed Web of Science ®Google Scholar
• Larson K, Ramig LO, Scherer RC. Acoustic and glottographic voice analysis during drug-related fluctuations in Parkinson’s disease. J. Med. Speech Lang. Pathol.2, 211–226 (1994).
   Google Scholar
• Skodda S, Visser W, Schlegel U. Short- and long-term dopaminergic effects on dysarthria in early Parkinson’s disease. J. Neural Transm.117, 197–205 (2010).
   PubMed Web of Science ®Google Scholar
• Spencer K, Morgan K, Blond E. Dopaminegic medication effects on the speech of individuals with Parkinson’s disease. J. Med. Speech Lang. Pathol.17, 125–144 (2009).
   Web of Science ®Google Scholar
• Biary N, Pimental PA, Langenberg PW. A double-blind trial of clonazepan in the treatment of parkinsonian dysarthria. Neurology38, 255–258 (1988).
   PubMed Web of Science ®Google Scholar
• Ghika J, Ghika-Schmid F, Fankhauser H et al. Bilateral contemporaneous posteroventral pallidotomy for the treatment of Parkinson’s disease: neuropsychological and neurological side effects, report of four cases and review of the literature. J. Neurosurg.91, 313–321 (1999).
   PubMed Web of Science ®Google Scholar
• Krack P, Batir A, VanBiercom N et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N. Engl. J. Med.345, 1925–1934 (2003).
   Google Scholar
• Gentil M, Garcia-Ruiz P, Pollak P, Benabid A-L. Effect of stimulation of the subthalamic nucleus on oral control of patients with Parkinsonism. J. Neurol. Neurosurg. Psychiatry67, 329–333 (1999).
   PubMed Web of Science ®Google Scholar
• Gentil M, Garcia-Ruiz P, Pollak P, Benabid A-L. Effect of bilateral deep-brain stimulation on oral control of patients with Parkinsonism. Eur. Neurol.44, 147–152 (2000).
   PubMed Web of Science ®Google Scholar
• Gentil M, Chauvin P, Pinto S, Pollak P, Benabid A-L. Effect of bilateral stimulation of the subthalamic nucleus on Parkinsonian voice. Brain Lang.78, 233–240 (2001).
   PubMed Web of Science ®Google Scholar
• Gentil M, Pinto S, Pollak P, Benabid A-L. Effect of bilateral stimulation of the subthalamic nucleus on Parkinsonian dysarthria. Brain Lang.85, 190–196 (2003).
   PubMed Web of Science ®Google Scholar
• Pinto S, Gentil M, Krack P et al. Changes induced by levodopa and subthalamic nucleus stimulation on Parkinsonian speech. Mov. Disord.20(11), 1507–1515 (2005).
   PubMed Web of Science ®Google Scholar
• Tripoliti E, Zrino L, Martinez-Torres I et al. Effects of contact location and voltage amplitude on speech and movement in bilateral subthalamic nucleus deep brain stimulation. Mov. Disord.23, 2377–2383 (2008).
   PubMedGoogle Scholar
• Romito LM, Albanese A. Dopaminergic therapy and subthalamic stimulation in Parkinson’s disease: a review of 5-year reports. J Neurol.257(Suppl. 2), S298–S304 (2010).
   PubMed Web of Science ®Google Scholar
• Ramig LO, Fox C, Sapir S. Speech treatment for Parkinson’s disease. Expert Rev. Neurother.8, 297–309 (2008).
   PubMedGoogle Scholar
• Sapir S, Ramig L, Fox C. Speech and swallowing disorders in Parkinson’s disease. Curr. Opin. Otolaryngol. Head Neck Surg.16, 205–210 (2008).
   PubMed Web of Science ®Google Scholar
• Törnqvist AL, Schalén L, Rehncrona S. Effects of different electrical parameter settings on the intelligibility of speech in patients with Parkinson’s disease treated with subthalamic deep brain stimulation. Mov. Disord.20, 416–423 (2005).
   PubMed Web of Science ®Google Scholar
• Astrom M, Tripoliti E, Hariz MI et al. Patient-specific model-based investigation of speech intelligibility and movement during deep brain stimulation. Stereotach. Funct. Neurosurg.88, 224–233 (2010).
   PubMed Web of Science ®Google Scholar
• Tommasi G, Krack P, Fraix V et al. Pyramidal tract side effects induced by deep brain stimulation of the subthalamic nucleus. J. Neurol. Neurosurg. Psychiatry79, 813–819 (2008).
   PubMedGoogle Scholar
• Rosen K, Kent RD, Duffy JR. Task-based profile of vocal intensity decline in Parkinson’s disease. Folia Phoniat. Logoped.57, 28–37 (2005).
   PubMed Web of Science ®Google Scholar
• Caligiuri M. The influence of speaking rate on articulatory hypokinesia in Parkinsonian dysarthria. Brain Lang.36, 493–502 (1989).
   PubMed Web of Science ®Google Scholar
• Liss JM, Spitzer SM, Caviness JN, Adler C. The effects of familiarization on intelligibility and lexical segmentation in hypokinetic and ataxic dysarthria. J. Acoust. Soc. Am.112, 3022–3030 (2002).
   PubMed Web of Science ®Google Scholar
• Sapir S, Ramig LO, Spielman JL, Fox C. Formant centralization ratio: a proposal for a new acoustic measure of dysarthric speech. J. Speech Lang. Hear. Res.53, 114–125 (2010).
   PubMed Web of Science ®Google Scholar
• Skodda S, Visser W, Schlegel U. Vowel articulation in Parkinson’s disease. J. Voice DOI: 10.1016/j.jvoice.2010.01.009 (2010) (Epub ahead of print).
   Google Scholar
• Bartels AL, Leenders KL. Parkinson’s disease: the syndrome, the pathogenesis and pathophysiology. Cortex45, 915–921 (2009).
   PubMed Web of Science ®Google Scholar
• Demirci M, Grill S, McShane L, Hallet M. Impairment of kinesthesia in Parkinson’s disease. Neurology45, A218 (1995).
   Google Scholar
• Desmurget M, Grafton ST, Vindras P, Gréa H, Turner RS. Basal ganglia network mediates the control of movement amplitude. Exp. Brain Res.153, 197–209 (2003).
   PubMed Web of Science ®Google Scholar
• Desmurget M, Grafton ST, Vindras P, Gréa H, Turner RS. The basal ganglia network mediates the planning of movement amplitude. Eur. J. Neurosci.19, 2871–2880 (2004).
   PubMed Web of Science ®Google Scholar
• Hallet M. Sensorimotor integration and mysterious sensory phenomena in movement disorders. In: Motor Control. Hallet M (Ed.) American Academy of Neurology, MN, USA (1997).
   Google Scholar
• Morris M, Iansek R, Matyas T, Summers J. Abnormalities in the stride length-cadence relation in Parkinsonian gait. Mov. Disord.13, 61–69 (1998).
   PubMed Web of Science ®Google Scholar
• Demirci M, Grill S, McShane L, Hallett M. A mismatch between kinesthetic and visual perception in Parkinson’s disease. Ann. Neurol.41, 781–788 (1997).
   PubMed Web of Science ®Google Scholar
• Jobst EE, Melnick ME, Byl NN, Dowling GA, Aminoff MJ. Sensory perception in Parkinson’s disease. Arch. Neurol.54, 450–454 (1997).
   PubMedGoogle Scholar
• Klockgether T, Borutta M, Rapp H, Spieder S, Dichgans J. A defect of kinesthesia in Parkinson’s disease. Brain120, 460–465 (1997).
   Google Scholar
• Schneider S, Diamond SG, Markham CH. Deficits in orofacial sensorimotor function in Parkinson’s disease. Ann. Neurol.19, 275–282 (1986).
   PubMed Web of Science ®Google Scholar
• Diamond SG, Schneider JS, Markham CH. Oral sensorimotor defects in people with Parkinson’s disease. Adv. Neurol.45, 335–338 (1987).
   PubMedGoogle Scholar
• Rickards C, Cody FW. Proprioceptive control of wrist movements in Parkinson’s disease. Brain120, 977–990 (1997).
   PubMed Web of Science ®Google Scholar
• Schneider JS, Lidsky TI. Basal Ganglia and Behavior: Sensory Aspects of Motor Functioning. Hans Huber, Toronto, Canada (1987).
   Google Scholar
• Graber S, Hertrich I, Daum I, Spieker S, Ackermann H. Speech perception deficits in Parkinson’s disease: underestimation of time intervals compromises identification of durational phonetic contrasts. Brain Lang.82, 65–74 (2002).
   PubMed Web of Science ®Google Scholar
• Ho AK, Bradshaw JL, Iansek R, Alfredson R. Speech volume regulation in Parkinson’s disease: Effects of implicit cues and explicit instructions. Neuropsychologia37, 1453–1460 (1999).
   PubMed Web of Science ®Google Scholar
• Ho AK, Iansek R, Bradshaw JL. Regulations of parkinsonian speech volume: the effect of interlocuter distance. J. Neurol. Neurosurg. Psychiatry67, 199–202 (1999).
   PubMed Web of Science ®Google Scholar
• Ho A, Bradshaw JL, Iansek T. Volume perception in Parkinsonian speech. Mov. Disord.15, 1125–1131 (2000).
   PubMed Web of Science ®Google Scholar
• Solomon NP, Robin DA, Lorell DM, Rodnitzky RL, Luschei ES. Tongue function testing in Parkinson’s Disease: indicators of fatigue. In Motor Speech Disorders: Advances in Assessment and Treatment. Till JA, Yorkston KM, Beukelman R (Eds). Paul H Brooks, MD, USA, 147–160 (1994).
   Google Scholar
• Hammer MJ. Design of a new somatosensory stimulus delivery device for measuring laryngeal mechanosensory detection thresholds in humans. IEEE Trans. Biomed. Eng.56(4), 1154–1159 (2009).
   PubMedGoogle Scholar
• Hammer MJ, Barlow SM. Laryngeal somatosensory deficits in Parkinson’s disease: implications for speech respiratory and phonatory control. Exp. Brain Res.201(3), 401–409 (2010).
   PubMed Web of Science ®Google Scholar
• Fox C, Morrison C, Ramig L, Sapir S. Current perspectives on the Lee Silverman Voice Treatment (LSVT®). Am. J. Speech Lang. Pathol.11, 111–123 (2002).
   Web of Science ®Google Scholar
• Kiran S, Larson C. Effect of duration of pitch-shifted feedback on vocal responses in patients with Parkinson’s disease. J. Speech Lang. Hear. Res.44, 975–987 (2001).
   PubMedGoogle Scholar
• Liotti M, Vogel D, Sapir S, Ramig L, New P, Fox P. Abnormal auditory gating in Parkinson’s disease before & after LSVT. Presented at: The Annual Meeting of the American Speech, Language and Hearing Association. Washington DC, USA, 16–19 November (2000).
   Google Scholar
• Ramig L, Pawlas A, Countryman S. The Lee Silverman Voice Treatment (LSVT): a Practical Guide to Treating the Voice and Speech Disorders in Parkinson Disease. National Center for Voice and Speech, IA, USA (1995).
   Google Scholar
• Ramig L, Sapir S, Countryman S et al. Intensive voice treatment (LSVT®) for individuals with Parkinson disease: a two-year follow-up. J. Neurol. Neurosurg. Psychiatry71, 493–498 (2001).
   PubMed Web of Science ®Google Scholar
• Ramig L, Sapir S, Fox C, Countryman S. Changes in vocal intensity following intensive voice treatment (LSVT®) in individuals with Parkinson disease: a comparison with untreated patients and normal age-matched controls. Mov. Disord.16, 79–83 (2001).
   PubMed Web of Science ®Google Scholar
• Cunnington R, Iansek R, Bradshaw JL. Movement-related potentials in Parkinson’s disease: external cues and attentional strategies. Mov. Disord.14, 63–68 (1999).
   PubMed Web of Science ®Google Scholar
• Oliveira RM, Gurd JM, Nixon P, Marshall JC, Passingham RE. Micrographia in Parkinson’s disease: the effect of providing external cues. J. Neurol. Neurosurg. Psychiatry.63, 429–433 (1997).
   PubMed Web of Science ®Google Scholar
• Rochester L, Rafferty D, Dotchin C, Msuya O, Minde V, Walker RW. The effect of cueing therapy on single and dual-task gait in a drug naïve population of people with Parkinson’s disease in northern Tanzania. Mov. Disord.25, 906–911 (2010).
   PubMed Web of Science ®Google Scholar
• Bohnen NI, Kaufer DI, Hendrickson R et al. Cognitive correlates of cortical cholinergic denervation in Parkinson’s disease and Parkinsonian dementia. J. Neuro.253, 242–247 (2006).
   PubMed Web of Science ®Google Scholar
• Rowe J, Stephan KE, Friston K, Frackowiak R, Lees A, Passingham R. Attention to action in Parkinson’s disease: impaired effective connectivity among frontal cortical regions. Brain.125, 276–289 (2002).
   PubMed Web of Science ®Google Scholar
• Morris ME, Iansek R, Matyas TA, Summers JJ. Stride length regulation in Parkinson’s disease. Normalization strategies and underlying mechanisms. Brain119(2), 551–568 (1996).
   PubMed Web of Science ®Google Scholar
• Sapir S, Ramig L, Hoyt P, O’Brien C, Hoehn M. Phonatory-respiratory effort (LSVT®) vs. respiratory effort treatment for hypokinetic dysarthria: comparing speech loudness and quality before and 12 months after treatment. Folia Phoniatr.54, 296–303 (2002).
   Web of Science ®Google Scholar
• Allan CM. Treatment of non-fluent speech resulting from neurological disease: treatment of dysarthria. Br. J. Disord. Comm.5, 3–5 (1970).
   PubMedGoogle Scholar
• Greene HCL. The Voice and Its Disorders. Pitman Medical, London, UK (1980).
   Google Scholar
• Sarno MT. Speech impairment in Parkinson’s disease. Arch. Phys. Med. Rehabil.49(5), 269–275 (1968).
   PubMedGoogle Scholar
• Weiner WJ, Lang AE. Movement Disorders: A Comprehensive Survey. Futura, NY, USA (1989).
   Google Scholar
• Scott S, Caird FL. Speech therapy for Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry.46, 140–144 (1983).
   PubMed Web of Science ®Google Scholar
• Robertson S, Thompson F. Speech therapy in Parkinson’s disease: a study of efficacy and long term effects of intensive treatment. Br. J. Disord. Commun.19, 213–224 (1984).
   PubMedGoogle Scholar
• Johnson J, Pring T. Speech therapy and Parkinson’s disease: a review and further data. Br. J. Disord. Comm.125, 183–194 (1990).
   Google Scholar
• Ramig L, Countryman S, Thompson L, Horii, Y. A comparison of two forms of intensive speech treatment for Parkinson disease. J. Speech Hear. Res.38, 1232–1251 (1995).
   PubMedGoogle Scholar
• Speech therapy in Parkinson’s disease. Mov. Disord.17(4), S163–S166 (2002).
   Google Scholar
• Robey RR, Schultz MC. A model for conducting clinical-outcome research: an adaptation of the standard protocol for use in aphasiology. Aphasiology12, 787–810 (1998).
   Web of Science ®Google Scholar
• Ramig L, Mead C, Scherer R, Horii Y, Larson K, Kohler D. Voice therapy and Parkinson’s disease: a longitudinal study of efficacy. Presented at: The Clinical Dysarthria Conference. San Diego, CA, USA, 4–7 February (1988).
   Google Scholar
• Ramig L, Dromey C. Aerodynamic mechanisms underlying treatment-related changes in vocal intensity in patients with Parkinson disease. J. Speech Hear. Res.39, 798–807 (1996).
   PubMedGoogle Scholar
• Cohen J. Statistical Power Analysis for the Behavioral Sciences (2nd Edition). Lawrence Erlbaum, NY, USA (1988).
   Google Scholar
• Dromey C, Ramig L, Johnson A. Phonatory and articulatory changes associated with increased vocal intensity in Parkinson disease: a case study. J. Speech Hear. Res.38, 751–763 (1995).
   PubMedGoogle Scholar
• Spielman J, Borod J, Ramig L. Effects of intensive voice treatment (LSVT) on facial expressiveness in Parkinson’s disease: preliminary data. Cog. Behav. Neurology16, 177–188 (2003).
   PubMedGoogle Scholar
• El-Sharkawi A, Ramig LO, Logemann JA et al. Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT®): a pilot study. J. Neurol. Neurosurg. Psychiatry71, 31–36 (2002).
   Google Scholar
• Dishman RK, Berthoud HR, Booth FW et al. Neurobiology of exercise. Obesity14(3), 345–356 (2006).
   PubMed Web of Science ®Google Scholar
• Dromey C, Ramig L. Intentional changes in sound pressure level and rate: their impact on measures of respiration, phonation, and articulation. J. Speech Lang. Hear. Res.41, 1003–1018 (1998).
   PubMed Web of Science ®Google Scholar
• Kleinow J, Smith A, Ramig L. Speech stability in idiopathic Parkinson disease: effects of rate and loudness manipulations. J. Speech Lang. Hear. Res.44(5), 1041–1051 (2001).
   PubMed Web of Science ®Google Scholar
• Ramig L, Sapir S, Baker K et al. The ‘big picture’ on the role of phonation in the treatment of individuals with motor speech disorders: Or ‘what’s up with loud?’ Presented at: The Tenth Biennial Conference on Motor Speech. San Antonio, TX, USA, 2–6 February (2000).
   Google Scholar
• Tjaden K, Wilding GE. Rate and loudness manipulations in dysarthria: acoustic and perceptual findings. J. Speech Lang. Hear. Res.47(4), 766–783 (2004).
   PubMed Web of Science ®Google Scholar
• Watson PJ, Hughes D. The relationship of vocal loudness manipulation to prosodic F0 and durational variables in healthy adults. J. Speech Lang. Hear. Res.636–644 (2006).
   PubMedGoogle Scholar
• Liotti M, Ramig LO, Vogel D et al. Hypophonia in Parkinson’s disease. Neural correlates of voice treatment revealed by PET. Neurology60, 432–440 (2003).
   PubMed Web of Science ®Google Scholar
• Will L, Spielman J, Ramig L. Stimulated or trained loudness: is there a difference and does it matter? Presented at: The Conference on Motor Speech Disorders. Austin, TX, USA, 23–26 March 2006.
   Google Scholar
• Schulman R. Articulatory dynamics of loud and normal speech. J. Acoust. Soc. Am.85, 295–312 (1989).
   PubMed Web of Science ®Google Scholar
• Kleim JA, Napper RMA, Swain RA, Armstrong KE, Jones TA, Greenough WT. Selective synaptic plasticity in the cerebellar cortex of the rat following complex motor learning. Soc. Neurosci. Abstr.20(2), 1435 (1994).
   Google Scholar
• Narayana S, Fox PT, Zhang W et al. Neural correlates of efficacy of voice therapy in Parkinson’s disease identified by performance-correlation analysis. Hum. Brain Mapp.31, 222–236 (2010).
   PubMed Web of Science ®Google Scholar
• Narayana S, Vogel D, Brown S et al. Mechanism of action of voice therapy in Parkinson’s hypophonia – a PET study. Presented at: The 11th Annual Meeting of the Organization for Human Brain Mapping. Toronto, Ontario, Canada, 12–16 June (2005).
   Google Scholar
• Fox C, Ramig L, Ciucci M et al. The science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders. Semin. Speech Lang.27, 283–299 (2006).
   PubMedGoogle Scholar
• Ofer-Noy N, Dudai Y, Karni A. Skill learning in mirror reading: how repetition determines acquisition. Cog. Brain Res.17, 507–521 (2003).
   PubMedGoogle Scholar
• Tillerson J, Miller G. Forced limb-use and recovery following brain injury. Neuroscientist8, 574–585 (2002).
   PubMedGoogle Scholar
• Berardelli A, Rothwell JC, Thompson PD, Hallett M. Pathophysiology of bradykinesia in Parkinson’s disease. Brain124, 2131–2146 (2001).
   PubMed Web of Science ®Google Scholar
• Allen G. Segmental timing control in speech production. J. Phon.1, 219–237 (1973).
   Google Scholar
• Dromey C, Ramig L. The effect of lung volume on selected phonatory and articulatory variables. J. Speech Lang. Hear. Res.41, 491–502 (1998).
   PubMed Web of Science ®Google Scholar
• Gandour J, Dechongkit S, Ponglorpisit S, Khunadorn F. Speech timing at the sentence level in Thai after unilateral brain damage. Brain Lang.46, 419–438 (1994).
   PubMed Web of Science ®Google Scholar
• Cookman S, Verdolini K. Interrelation of mandibular laryngeal functions. J. Voice13, 11–24 (1999).
   PubMed Web of Science ®Google Scholar
• Higgins MB, Netsell R, Schulte L. Vowel-related differences in laryngeal articulatory and phonatory function. J. Speech Lang. Hear. Res.41, 712–724 (1998).
   PubMed Web of Science ®Google Scholar
• Larson KK, Sapir S. Orolaryngeal reflex responses to changes in affective state. J. Speech Lang. Hear. Res.38, 990–1000 (1995).
   Google Scholar
• McClean MD, Tasko SM. Association of orofacial with laryngeal and respiratory motor output during speech. Exp. Brain Res.146, 481–489 (2002).
   PubMed Web of Science ®Google Scholar
• Sapir S. The intrinsic pitch of vowels: theoretical, physiological, and clinical considerations. J. Voice3, 44–51 (1989).
   Google Scholar
• Sapir S, Larson KK. Supralaryngeal muscle activity during sustained vibrato in four sopranos: surface EMG findings. J. Voice7, 213–218 (1993).
   PubMedGoogle Scholar
• Roy N, Nissen SL, Dromey C, Sapir S. Articulatory changes in muscle tension dysphonia: evidence of vowel space expansion following manual circumlaryngeal therapy. J. Commun. Disord.42, 124–135 (2009).
   PubMed Web of Science ®Google Scholar
• von Cramon D, Jürgens U. The anterior cingulate cortex and the phonatory control in monkey and man. Neurosci. Biobehav. Rev.7, 423–425 (1983).
   PubMedGoogle Scholar
• Jürgens U, Kirzinger A, von Cramon D. The effects of deep-reaching lesions in the cortical face area on phonation. A combined case report and experimental monkey study. Cortex18, 125–130 (1982).
   PubMed Web of Science ®Google Scholar
• Kitchen DM, Cheney DL, Seyfarth RM. Male chacma baboons (Papio hamadryas ursinus) discriminate loud call contests between rivals of different relative ranks. Anim. Cogn.8, 1–6 (2005).
   PubMed Web of Science ®Google Scholar
• Leinonen L, Laakso ML, Carlson S, Linnankoski I. Shared means and meanings in vocal expression of man and macaque. Logoped. Phoniatr. Vocol.28, 53–61 (2003).
   PubMedGoogle Scholar
• Jürgens U. Neuronal control of mammalian vocalization, with special reference to the squirrel monkey. Naturwissenschaften85, 376–388 (1998).
   PubMed Web of Science ®Google Scholar
• Sapir S, Aronson AE. Aphonia after closed head injury: aetiologic considerations. Br. J. Disord. Commun.20, 289–296 (1985).
   PubMedGoogle Scholar
• McClean M, Tasko S. Association of orofacial muscle activity and movement during changes in speech rate and intensity. J. Speech Lang. Hear. Res.46, 1387–1400 (2003).
   PubMed Web of Science ®Google Scholar
• Wohlert A, Hammen V. Lip muscle activity related to speech rate and loudness. J. Speech Lang. Hear. Res.43, 1229–1239 (2000).
   PubMed Web of Science ®Google Scholar
• Sapir S, Ramig L, Fox C. The Lee Silverman Voice Treatment for voice, speech and other orofacial disorders in patients with Parkinson’s disease. Future Neurol.1, 563–570 (2006).
   Google Scholar
• Jürgens U, Zwirner P. The role of the periaqueductal grey in limbic and neocortical vocal fold control. Neuroreport7, 2921–2923 (1996).
   PubMed Web of Science ®Google Scholar
• Meissner I, Sapir S, Kokmen E, Stein SD. The paramedian diencephalic syndrome: a dynamic phenomenon. Stroke18, 380–385 (1987).
   PubMed Web of Science ®Google Scholar
• Sapir S, Campbell C, Larson C. Effect of geniohyoid, cricothyroid and sternothyroid muscle stimulation on voice fundamental frequency of electrically elicited phonation in rhesus macaque. Laryngoscope91, 457–468 (1981).
   PubMed Web of Science ®Google Scholar
• West RA, Larson CR. Neurons of the anterior mesial cortex related to faciovocal activity in the awake monkey. J. Neurophysiol.74, 1856–1869 (1995).
   PubMedGoogle Scholar
• de Swart BJ, Willemse SC, Maassen BA, Horstink MW. Improvement of voicing in patients with Parkinson’s disease by speech therapy. Neurology60(3), 498–500 (2003).
   PubMed Web of Science ®Google Scholar
• Liotti M, Ramig L. Improvement of voicing in patients with Parkinson’s disease by speech therapy. Neurology61(9), 1316–1317 (2003).
   PubMedGoogle Scholar
• Tillerson J, Cohen AD, Philhower J, Miller GW, Zigmond MJ, Schallert T. Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. J. Neuroscience21, 4427–4435 (2001).
   PubMedGoogle Scholar
• Tillerson J, Caudle WM, Reveron ME, Miller GW. Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson’s disease. Neuroscience119, 899–911 (2003).
   PubMed Web of Science ®Google Scholar
• Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci.13, 266–271 (1990).
   PubMed Web of Science ®Google Scholar
• Graybiel AM. The basal ganglia and chunking of action repertoires. Neurobiol. Learn. Mem.70, 119–136 (1998).
   PubMed Web of Science ®Google Scholar
• Yorkston K, Spencer KA, Duffy JR. Behavioral management of respiratory/phonatory dysfunction from dysarthria: a systematic review of the evidence. J. Med. Speech Lang. Pathol.11, xiii–xxxviii (2003).
   Web of Science ®Google Scholar
• Yorkston KM, Hakel M, Beukelman DR, Fager S. Evidence for effectiveness of treatment of loudness, rate, or prosody in dysarthria: a systematic review. J. Med. Speech Lang. Pathol.15(2), xi–xxxvi (2007).
   Google Scholar
• Halpern A, Matos C, Ramig LO, Petska J, Spielman J. LSVTC – a PDA supported speech treatment for Parkinson’s disease. Presented at: The 9th International Congress of Parkinson’s Disease and Movement Disorders. New Orleans, LA, USA 2–5 March (2005).
   Google Scholar
• Ward E, Theodoros D, Murdoch B, Silburn P. Changes in maximum capacity tongue function following the Lee Silverman Voice Treatment program. J. Med. Speech Lang. Pathol.8, 331–335 (2000).
   Web of Science ®Google Scholar
• Howell S, Tripoliti E, Pring T. Delivering the Lee Silverman Voice Treatment (LSVT) by web camera: a feasibility study. Int. J. Lang. Commun. Disord.44, 287–300 (2009).
   PubMed Web of Science ®Google Scholar
• Tindall LR, Huebner RA, Stemple JC, Kleinert HL. Videophone-delivered voice therapy: a comparative analysis of outcomes to traditional delivery for adults with Parkinson’s disease. Telemed. J. E Health14, 1070–1077 (2008).
   PubMed Web of Science ®Google Scholar
• Countryman S, Ramig L. Effects of intensive voice therapy on voice deficits associated with bilateral thalamotomy in Parkinson’s disease: a case study. J. Med. Speech Lang. Pathol.1, 233–250 (1993).
   Google Scholar
• Halpern A, Spielman J, Ramig L, Down I, Gilley P. Speech Treatment for Individuals with IPD Post Deep Brain Stimulation: LSVT-DBS. Presented at: The 15th Biennial Conference on Motor Speech. Savannah, GA, USA, 3–7 March 2010 (2010).
   Google Scholar
• Sapir S, Halpern A, Spielman J, Ramig L, Gilley P. Speech Treatment for individuals with idiopathic Parkinson’s disease post DBS-STN: LSVT-DBS. Presented at: The Second International Symposium on Basal Ganglia Speech Disorders and Deep Brain Stimualtion. Aix en Provence, France, 29 June–1 July (2010).
   Google Scholar
• Tassorelli C, Buscone S, Sandrini G et al. The role of rehabilitation in deep brain stimulation of the subthalamic nucleus for Parkinson’s disease: a pilot study. Parkinsonism Relat Disord.15, 675–681 (2009).
   PubMed Web of Science ®Google Scholar
• Countryman S, Ramig L, Pawlas A. Speech and voice deficits in Parkinsonian Plus syndromes: can they be treated? J. Med. Speech Lang. Pathol.2(3), 211–225 (1994).
   Google Scholar
• Duncan S. Preliminary data on effects of behavioral and levodopa therapies of speech-accompanying gesture in Parkinson’s disease. Presented at: The ICSLP Meeting. Denver, CO, USA, 16–20 September (2002).
   Google Scholar
• Theodoros DG, Constantinescu G, Russell TG et al. Treating the speech disorder in Parkinson’s disease online. J. Telemed. Telecare.12, S3, 88–91 (2006).
   PubMedGoogle Scholar
• Bauer J, Mittal J, Larson C, Hain T. Vocal responses to unanticipated perturbations in voice loudness feedback: an automatic mechanism for stabilizing voice amplitude. J. Acous. Soc. Am.119, 2363–2371 (2006).
   PubMed Web of Science ®Google Scholar
• Ciucci MR, Ma ST, Fox C, Kane JR, Ramig LO, Schallert T. Qualitative changes in ultrasonic vocalization in rats after unilateral dopamine depletion or haloperidol: a preliminary study. Behav. Brain Res.182(2), 284–289 (2007).
   PubMed Web of Science ®Google Scholar
• Miller JE, Burkett ZD, White SA. Birdsong as a model system for early detection of Parkinson disease. Presented at: Annual Society for Neuroscience Meeting, Chicago, IL, USA, 21–27 October (2009).
   Google Scholar
• Fox CM, Farley BG, Ramig LO, McFarland D. An integrated speech and physical therapy approach for Parkinson disease: Training BIG and LOUD. Mov. Disord.22(Suppl. 16), S98–S99 (2007)
   Google Scholar
• Constantinescu GA, Theodoros DG, Russell TG, Ward EC, Wilson SJ, Wootton R. Home-based speech treatment for Parkinson’s disease delivered remotely: a case report. J. Telemed. Telecare16, 100–104 (2010).
   PubMed Web of Science ®Google Scholar
• Ramig L, Countryman S, O’Brien C, Hoehn M, Thompson L. Intensive speech treatment for individuals with Parkinson’s disease: short- and long-term comparison of two techniques. Am. Acad. Neurol.47, 1496–1504 (1996).
   PubMed Web of Science ®Google Scholar
• Till JA, Yorkston KM, Beukelman R. Motor Speech Disorders: Advances in Assessment and Treatment. Paul H Brooks, Baltimore, MD, USA (1994).
   Google Scholar